Your browser doesn't support javascript.
loading
Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study.
Chen, Ye; Zhou, Yu-Wen; Cheng, Ke; Li, Zhi-Ping; Luo, De-Yun; Qiu, Meng; Li, Qiu; Wang, Xin; Shen, Ya-Li; Cao, Dan; Yang, Yu; Bi, Feng; Liu, Ji-Yan; Gou, Hong-Feng.
Affiliation
  • Chen Y; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Zhou YW; Department of Biotherapy, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Cheng K; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Li ZP; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Luo DY; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Qiu M; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Li Q; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Wang X; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Shen YL; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Cao D; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Yang Y; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Bi F; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Liu JY; Department of Biotherapy, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Gou HF; Department of Abdominal Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu, People's Republic of China.
Oncologist ; 26(8): e1320-e1326, 2021 08.
Article in En | MEDLINE | ID: mdl-33830591
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2021 Type: Article